How Zimmer Biomet Zoomed Past Wall Street's Third-Quarter Estimates
All you have to do to understand how the coronavirus pandemic has impacted Zimmer Biomet Holdings (NYSE: ZBH) is to look at its stock chart. The musculoskeletal healthcare company's shares plunged nearly 50% earlier this year and still haven't completely recovered.
Zimmer Biomet announced its third-quarter results before the market opened on Friday, and it looks like its business is bouncing back better than expected. Here are the highlights from the quarterly update.
Source Fool.com